Cargando…
Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician
Real-world studies have become increasingly important in providing evidence of treatment effectiveness in clinical practice. While randomized clinical trials (RCTs) are the “gold standard” for evaluating the safety and efficacy of new therapeutic agents, necessarily strict inclusion and exclusion cr...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223979/ https://www.ncbi.nlm.nih.gov/pubmed/30357570 http://dx.doi.org/10.1007/s12325-018-0805-y |
_version_ | 1783369512636121088 |
---|---|
author | Blonde, Lawrence Khunti, Kamlesh Harris, Stewart B. Meizinger, Casey Skolnik, Neil S. |
author_facet | Blonde, Lawrence Khunti, Kamlesh Harris, Stewart B. Meizinger, Casey Skolnik, Neil S. |
author_sort | Blonde, Lawrence |
collection | PubMed |
description | Real-world studies have become increasingly important in providing evidence of treatment effectiveness in clinical practice. While randomized clinical trials (RCTs) are the “gold standard” for evaluating the safety and efficacy of new therapeutic agents, necessarily strict inclusion and exclusion criteria mean that trial populations are often not representative of the patient populations encountered in clinical practice. Real-world studies may use information from electronic health and claims databases, which provide large datasets from diverse patient populations, and/or may be observational, collecting prospective or retrospective data over a long period of time. They can therefore provide information on the long-term safety, particularly pertaining to rare events, and effectiveness of drugs in large heterogeneous populations, as well as information on utilization patterns and health and economic outcomes. This review focuses on how evidence from real-world studies can be utilized to complement data from RCTs to gain a more complete picture of the advantages and disadvantages of medications as they are used in practice. Funding: Sanofi US, Inc. |
format | Online Article Text |
id | pubmed-6223979 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-62239792018-11-19 Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician Blonde, Lawrence Khunti, Kamlesh Harris, Stewart B. Meizinger, Casey Skolnik, Neil S. Adv Ther Review Real-world studies have become increasingly important in providing evidence of treatment effectiveness in clinical practice. While randomized clinical trials (RCTs) are the “gold standard” for evaluating the safety and efficacy of new therapeutic agents, necessarily strict inclusion and exclusion criteria mean that trial populations are often not representative of the patient populations encountered in clinical practice. Real-world studies may use information from electronic health and claims databases, which provide large datasets from diverse patient populations, and/or may be observational, collecting prospective or retrospective data over a long period of time. They can therefore provide information on the long-term safety, particularly pertaining to rare events, and effectiveness of drugs in large heterogeneous populations, as well as information on utilization patterns and health and economic outcomes. This review focuses on how evidence from real-world studies can be utilized to complement data from RCTs to gain a more complete picture of the advantages and disadvantages of medications as they are used in practice. Funding: Sanofi US, Inc. Springer Healthcare 2018-10-24 2018 /pmc/articles/PMC6223979/ /pubmed/30357570 http://dx.doi.org/10.1007/s12325-018-0805-y Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Review Blonde, Lawrence Khunti, Kamlesh Harris, Stewart B. Meizinger, Casey Skolnik, Neil S. Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician |
title | Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician |
title_full | Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician |
title_fullStr | Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician |
title_full_unstemmed | Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician |
title_short | Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician |
title_sort | interpretation and impact of real-world clinical data for the practicing clinician |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223979/ https://www.ncbi.nlm.nih.gov/pubmed/30357570 http://dx.doi.org/10.1007/s12325-018-0805-y |
work_keys_str_mv | AT blondelawrence interpretationandimpactofrealworldclinicaldataforthepracticingclinician AT khuntikamlesh interpretationandimpactofrealworldclinicaldataforthepracticingclinician AT harrisstewartb interpretationandimpactofrealworldclinicaldataforthepracticingclinician AT meizingercasey interpretationandimpactofrealworldclinicaldataforthepracticingclinician AT skolnikneils interpretationandimpactofrealworldclinicaldataforthepracticingclinician |